Baoshan, Shanghai - Turtle Technology and Suzhou-based GenDx signed a strategic partnership agreement in Shanghai to jointly promote the commercial application of Digital ERA technology. Currently, the Digital ERA technology and products jointly developed by both companies can achieve precise nucleic acid quantification within 25 minutes.
This signing will comprehensively advance the deep cooperation between the two parties in the promotion of Digital ERA technology and products. They will further collaborate on the development of multiplex and Ultra-Multiplex Digital ERA amplification detection technologies, providing new technical and product services for more life science and cutting-edge molecular diagnostics developers. Additionally, based on the application of the AI assistant in the life science field, the Biobuddy system, the two parties will deepen their cooperation to accelerate the popularization of Digital ERA in an innovative way, supporting global innovation research in the life science field.
GenDx
Suzhou GenDx Gene Technology Co., Ltd. is committed to the research and development of molecular diagnostic POCT products and providing integrated on-site rapid solutions. The company possesses globally independent intellectual property rights in Enzymatic Reaction Amplification (ERA) technology. Based on this platform, it has developed multiple series of nucleic acid diagnostic reagents and supporting portable testing devices. Its products cover areas such as public health rapid testing, in vitro molecular diagnostics, and POCT diagnostic kits, striving to create rapid pathogen detection projects within 10-25 minutes. Currently, GenDx has established business partnerships with nearly a thousand universities, research institutes, and enterprises both domestically and internationally. As of November 2023, it has applied for over 40 patents, with 11 patents granted, and 3 core patents undergoing global PCT application.
Turtle Tech
Shanghai Turtle Technology Co., Ltd. is committed to leading the life sciences and molecular diagnostics into the digital era. Having been approved as the National Demonstration Center for Genetic Testing Technology and obtaining the first Digital PCR Metrological Evaluation Certificate, we have introduced a variety of digital PCR systems, and is the first to launch commercialized Digital Isothermal Systems globally. This marks a comprehensive technological innovation across the entire industrial chain, including genetic testing instruments, chip consumables, Ultra-Multiplex technology, and Ultra-High Specificity Polymerase. We have filed over 70 intellectual property applications, resulting in nearly 50 granted patents, including over 20 invention patents.
